Slight-Webb et al. suggested that the reduction of phosphorylated STAT3 is the primary mechanism responsible for disease suppression in lupus for mycophenolate mofetil, a current therapy for NPSLE (57). Here, STAT3 is linked to systemic lupus erythematosus.